Global Voriconazole Market 2020 Research Forecast 2026

Published On: Dec 2019

Format: PDF

Publisher: QY Research

Pages: 128

Report ID: 361419

The global Voriconazole market is valued at million US$ in 2020 and will reach million US$ by the end of 2026, growing at a CAGR of during 2020-2026. The objectives of this study are to define, segment, and project the size of the Voriconazole market based on company, product type, end user and key regions.

This report studies the global market size of Voriconazole in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Voriconazole in these regions.
This research report categorizes the global Voriconazole market by top players/brands, region, type and end user. This report also studies the global Voriconazole market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer
Teva
GeneTech Pharm
Novartis
Mylan
Squibb
Sandoz
Daiichi Sankyo
GSK
Cilag AG
Macherey-Nagel GmbH
Abbott
Takeda
Sichuan Beauty Sport Huakang Pharmaceutical
Jincheng HEALTH Pharmaceutical
Ebang Pharmaceutical
Aditya Pharma
Taj Pharmaceuticals

Market size by Product
Injection
Freeze-dried Powder
Market size by End User
Hospital
Clinic
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Voriconazole market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2026.
To understand the structure of Voriconazole market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Voriconazole companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Voriconazole submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Voriconazole are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Voriconazole market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Voriconazole Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Voriconazole Market Size Growth Rate by Product
1.4.2 Injection
1.4.3 Freeze-dried Powder
1.5 Market by End User
1.5.1 Global Voriconazole Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Voriconazole Market Size
2.1.1 Global Voriconazole Revenue 2015-2026
2.1.2 Global Voriconazole Sales 2015-2026
2.2 Voriconazole Growth Rate by Regions
2.2.1 Global Voriconazole Sales by Regions
2.2.2 Global Voriconazole Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Voriconazole Sales by Manufacturers
3.1.1 Voriconazole Sales by Manufacturers
3.1.2 Voriconazole Sales Market Share by Manufacturers
3.1.3 Global Voriconazole Market Concentration Ratio (CR5 and HHI)
3.2 Voriconazole Revenue by Manufacturers
3.2.1 Voriconazole Revenue by Manufacturers (2015-2020)
3.2.2 Voriconazole Revenue Share by Manufacturers (2015-2020)
3.3 Voriconazole Price by Manufacturers
3.4 Voriconazole Manufacturing Base Distribution, Product Types
3.4.1 Voriconazole Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Voriconazole Product Type
3.4.3 Date of International Manufacturers Enter into Voriconazole Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Voriconazole Sales by Product
4.2 Global Voriconazole Revenue by Product
4.3 Voriconazole Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Voriconazole Breakdown Data by End User

6 North America
6.1 North America Voriconazole by Countries
6.1.1 North America Voriconazole Sales by Countries
6.1.2 North America Voriconazole Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Voriconazole by Product
6.3 North America Voriconazole by End User

7 Europe
7.1 Europe Voriconazole by Countries
7.1.1 Europe Voriconazole Sales by Countries
7.1.2 Europe Voriconazole Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Voriconazole by Product
7.3 Europe Voriconazole by End User

8 Asia Pacific
8.1 Asia Pacific Voriconazole by Countries
8.1.1 Asia Pacific Voriconazole Sales by Countries
8.1.2 Asia Pacific Voriconazole Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Voriconazole by Product
8.3 Asia Pacific Voriconazole by End User

9 Central & South America
9.1 Central & South America Voriconazole by Countries
9.1.1 Central & South America Voriconazole Sales by Countries
9.1.2 Central & South America Voriconazole Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Voriconazole by Product
9.3 Central & South America Voriconazole by End User

10 Middle East and Africa
10.1 Middle East and Africa Voriconazole by Countries
10.1.1 Middle East and Africa Voriconazole Sales by Countries
10.1.2 Middle East and Africa Voriconazole Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Voriconazole by Product
10.3 Middle East and Africa Voriconazole by End User

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Business Overview
11.1.3 Pfizer Voriconazole Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Voriconazole Products Offered
11.1.5 Pfizer Recent Development
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Company Business Overview
11.2.3 Teva Voriconazole Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Teva Voriconazole Products Offered
11.2.5 Teva Recent Development
11.3 GeneTech Pharm
11.3.1 GeneTech Pharm Company Details
11.3.2 Company Business Overview
11.3.3 GeneTech Pharm Voriconazole Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GeneTech Pharm Voriconazole Products Offered
11.3.5 GeneTech Pharm Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Company Business Overview
11.4.3 Novartis Voriconazole Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Novartis Voriconazole Products Offered
11.4.5 Novartis Recent Development
11.5 Mylan
11.5.1 Mylan Company Details
11.5.2 Company Business Overview
11.5.3 Mylan Voriconazole Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Mylan Voriconazole Products Offered
11.5.5 Mylan Recent Development
11.6 Squibb
11.6.1 Squibb Company Details
11.6.2 Company Business Overview
11.6.3 Squibb Voriconazole Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Squibb Voriconazole Products Offered
11.6.5 Squibb Recent Development
11.7 Sandoz
11.7.1 Sandoz Company Details
11.7.2 Company Business Overview
11.7.3 Sandoz Voriconazole Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sandoz Voriconazole Products Offered
11.7.5 Sandoz Recent Development
11.8 Daiichi Sankyo
11.8.1 Daiichi Sankyo Company Details
11.8.2 Company Business Overview
11.8.3 Daiichi Sankyo Voriconazole Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Daiichi Sankyo Voriconazole Products Offered
11.8.5 Daiichi Sankyo Recent Development
11.9 GSK
11.9.1 GSK Company Details
11.9.2 Company Business Overview
11.9.3 GSK Voriconazole Sales, Revenue and Gross Margin (2015-2020)
11.9.4 GSK Voriconazole Products Offered
11.9.5 GSK Recent Development
11.10 Cilag AG
11.10.1 Cilag AG Company Details
11.10.2 Company Business Overview
11.10.3 Cilag AG Voriconazole Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Cilag AG Voriconazole Products Offered
11.10.5 Cilag AG Recent Development
11.11 Macherey-Nagel GmbH
11.12 Abbott
11.13 Takeda
11.14 Sichuan Beauty Sport Huakang Pharmaceutical
11.15 Jincheng HEALTH Pharmaceutical
11.16 Ebang Pharmaceutical
11.17 Aditya Pharma
11.18 Taj Pharmaceuticals

12 Future Forecast
12.1 Voriconazole Market Forecast by Regions
12.1.1 Global Voriconazole Sales Forecast by Regions 2020-2026
12.1.2 Global Voriconazole Revenue Forecast by Regions 2020-2026
12.2 Voriconazole Market Forecast by Product
12.2.1 Global Voriconazole Sales Forecast by Product 2020-2026
12.2.2 Global Voriconazole Revenue Forecast by Product 2020-2026
12.3 Voriconazole Market Forecast by End User
12.4 North America Voriconazole Forecast
12.5 Europe Voriconazole Forecast
12.6 Asia Pacific Voriconazole Forecast
12.7 Central & South America Voriconazole Forecast
12.8 Middle East and Africa Voriconazole Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Voriconazole Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer